179324-69-7 98%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2024-02-02
Product Details
- Product NameBortezomib
- CAS No.179324-69-7
- EINECS No.605-854-3
- MFC19H25BN4O4
- MW384.24
- AppearancesolidWhite
- density 1.214
- Melting point 122-124°C
- storage temp. Inert atmosphere,Store in freezer, under -20°C
Company Profile Introduction
As a research-driven pharmaceutical manufacturing organization, Laurus Labs has been developing and assisting its client organizations to succeed in innovative medicines that globally enhance the health outcomes for patients.
Since our inception in 2005, we have been developing and manufacturing Active Pharmaceutical Ingredients (APIs) and Intermediates. We quickly scaled our pharmaceutical value chain by attaining a global leadership position in APIs, including anti-retroviral (ARV), Oncology, Cardiovascular, and Gastro therapeutics. Our position was strengthened by our backward-integration capability while remaining highly regulatory compliant across all operations.
As our portfolio of pharmaceutical Ingredients & Finished Dosages was strengthened, in line with our vision, Laurus Labs extended its development and manufacturing solutions to multiple large pharmaceutical organizations.
We emerged as one of the most trusted and largest pharmaceutical Contract Development & Manufacturing Organizations (CDMO) in India for both generics and the proprietary space.
While small-molecule chemistry is ingrained in our DNA, Laurus Labs recognizes the potential and differential benefits of large molecules, namely biologicals and biotechnology products, in the healthcare and nutritional space. We permeated this domain with the inception of Laurus Bio and continue the commitment by investing and collaborating in Cell and Gene therapies.
As a company, we are committed to conducting our business with utmost transparency, integrity, and responsibility towards our employees, society, customers, and all our stakeholders. We consciously and consistently strive to achieve our sustainable development goals, as showcased in our Environmental, Social, and Governance (ESG) focus and performance.
Supplier other products
Recommended supplier
-
VIP1年
- Granules India Limited
- Bortezomib 179324-69-7 99%
- Inquiry
- 2024-03-22
-
VIP1年
- Kekule Life Sciences Limited
- 179324-69-7 99%
- Inquiry
- 2024-03-19
-
VIP1年
- Medec Dragon Private Limited
- 179324-69-7 Bortezomib 99%
- Inquiry
- 2024-03-19
-
VIP1年
- Aspen Biopharma Labs Pvt Ltd
- Bortezomib 179324-69-7 98%
- Inquiry
- 2024-03-16
-
VIP1年
- Myosynth Laboratories Pvt Ltd
- Bortezomib 98%
- Inquiry
- 2024-03-14
-
VIP1年
- Apicore Pharmaceuticals Pvt Ltd
- 179324-69-7 98%
- Inquiry
- 2024-03-07
-
VIP1年
- Mylan Laboratories Ltd
- 179324-69-7 Bortezomib 98%
- Inquiry
- 2024-03-06
-
VIP1年
- Khandelwal Laboratories Private Limited
- Bortezomib 179324-69-7 98%
- Inquiry
- 2024-03-06
-
VIP1年
- Shreyaa Medilife Private Limited
- Bortezomib 98%
- Inquiry
- 2024-03-04
-
VIP1年
- Mac Chem Products (India) Pvt Ltd (Naprod Group)
- 179324-69-7 98%
- Inquiry
- 2024-02-28
- Since:2021-02-01
- Address: Serene Chambers, Road No 7, Banjarahills, Hyderabad, Telangana-500 034, India.